Spinal versus General Anesthesia for Patients with Parkinson’s Disease

References

• Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson’s disease: a review of the evidence. Eur J Epidemiol. 2011;26(Suppl 1):S1–58.21626386
   PubMed Web of Science ®Google Scholar
• Moghal S, Rajput AH, D’Arcy C, Rajput R. Prevalence of movement disorders in elderly community residents. Neuroepidemiology. 1994;13:175–178. doi:10.1159/0001103768090259
   PubMed Web of Science ®Google Scholar
• Lang AE, Lozano AM. Parkinson’s disease: second of two parts. N Engl J Med. 1998;339:1130–1143. doi:10.1056/NEJM1998101533916079770561
   PubMed Web of Science ®Google Scholar
• Khoo TK, Yarnall AJ, Duncan GW, et al. The spectrum of nonmotor symptoms in early Parkinson disease. Neurology. 2013;80:276–281. doi:10.1212/WNL.0b013e31827deb7423319473
   PubMed Web of Science ®Google Scholar
• Oğuz E, Öztürk İ, Özkan D, Ergil J, Aydın GB. Parkinson’s disease and spinal anaesthesia. Turk J Anaesthesiol Reanim. 2014;42:280–282. doi:10.5152/TJAR.2014.4713527366437
   PubMedGoogle Scholar
• Christian CM, Waller JL, Moldenhauer CC. Postoperative rigidity following fentanyl anesthesia. Anesthesiology. 1983;58:275–277. doi:10.1097/00000542-198303000-000156829964
   PubMed Web of Science ®Google Scholar
• Krauss JK, Akeyson EW, Giam P, Jankovic J. Propofol-induced dyskinesias in Parkinson’s disease. Anesth Analg. 1996;83:420–422. doi:10.1097/00000539-199608000-000378694329
   PubMed Web of Science ®Google Scholar
• Zesiewicz TA, Hauser RA, Freeman A, Sullivan KL, Miller AM, Halim T. Fentanyl-induced bradykinesia and rigidity after deep brain stimulation in a patient with Parkinson disease. Clin Neuropharmacol. 2009;32:48–50. doi:10.1097/WNF.0b013e31817e23e319471184
   PubMed Web of Science ®Google Scholar
• Zornberg GL, Bodkin JA, Cohen BM. Severe adverse interaction between pethidine and selegiline. Lancet. 1991;337:246. doi:10.1016/0140-6736(91)92219-R1670882
   PubMed Web of Science ®Google Scholar
• Shaikh SI, Verma H. Parkinson’s disease and anaesthesia. Indian J Anaesth. 2011;55:228–234. doi:10.4103/0019-5049.8265821808393
   PubMedGoogle Scholar
• Gautam B, Baral B. Spinal anaesthesia for laparoscopic cholecystectomy in Parkinson’s disease. JNMA J Nepal Med Assoc. 2018;56:701–704. doi:10.31729/jnma.361130381769
   PubMed Web of Science ®Google Scholar
• Mu L, Sobotka S, Chen J, et al. Altered pharyngeal muscles in Parkinson disease. J Neuropathol Exp Neurol. 2012;71:520–530. doi:10.1097/NEN.0b013e318258381b22588389
   PubMed Web of Science ®Google Scholar
• Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol. 2003;2:107–116. doi:10.1016/S1474-4422(03)00307-712849267
   PubMed Web of Science ®Google Scholar
• DeLong MR, Juncos JL. Parkinson’s disease and other movement disorders In: Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL, editors. Harrison’s Principles of Internal Medicine. 17th ed. New York: McGraw-Hill Medical Publishers; 2008:2406–2417.
   Google Scholar
• Monteiro L, Souza-Machado A, Valderramas S, Melo A. The effect of levodopa on pulmonary function in Parkinson’s disease: a systematic review and meta-analysis. Clin Ther. 2012;34:1049–1055. doi:10.1016/j.clinthera.2012.03.00122465616
   PubMed Web of Science ®Google Scholar
• Galvez-Jimenez N, Lang AE. The perioperative management of Parkinson’s disease revisited. Neurol Clin. 2004;22:367–377. doi:10.1016/j.ncl.2004.01.00415062517
   PubMed Web of Science ®Google Scholar
• Neu HC, Connolly JJ, Schwertley FW, Ladwig HA, Brody AW. Obstructive respiratory dysfunction in parkinsonian patients. Am Rev Respir Dis. 1967;95:33–47. doi:10.1164/arrd.1967.95.1.336015923
   PubMed Web of Science ®Google Scholar
• Obenour WH, Stevens PM, Cohen AA, McCutchen JJ. The causes of abnormal pulmonary function in Parkinson’s disease. Am Rev Respir Dis. 1972;105:382–387. doi:10.1164/arrd.1972.105.3.3825011667
   PubMed Web of Science ®Google Scholar
• Mueller MC, Juptner U, Wuellner U, et al. Parkinson’s disease influences the perioperative risk profile in surgery. Langenbecks Arch Surg. 2009;394:511–515. doi:10.1007/s00423-008-0404-518712410
   PubMed Web of Science ®Google Scholar
• Pepper PV, Goldstein MK. Postoperative complications in Parkinson’s disease. J Am Geriatr Soc. 1999;47:967–972. doi:10.1111/jgs.1999.47.issue-810443858
   PubMed Web of Science ®Google Scholar
• Roizen MF, Fleisher LA. Anesthetic implications of concurrent diseases In: RD M, editor. Miller’s Anaesthesia. 7th ed. New York: Churchill-Livingstone; 2010:1167–1250.
   Google Scholar
• Nicholson G 1, Pereira AC, Hall GM. Parkinson’s disease and anaesthesia. Br J Anaesth. 2002;89:904–916. doi:10.1093/bja/aef26812453936
   PubMed Web of Science ®Google Scholar
• Rudra A, Rudra P, Chatterjee S, Das T, Ray M, Kumar P. Parkinson’s disease and anaesthesia. Indian J Anaesth. 2007;51:382.
   Google Scholar
• Kleinsasser A, Kuenszberg E, Loeckinger A, et al. Sevoflurane, but not propofol, significantly prolongs the Q-T interval. Anesth Analg. 2000;90:25–27. doi:10.1097/00000539-200001000-0000610624970
   PubMed Web of Science ®Google Scholar
• Muravchick S, Smith DS. Parkinsonian symptoms during emergence from general anaesthesia. Anesthesiology. 1995;82:305–307. doi:10.1097/00000542-199501000-000397832317
   PubMed Web of Science ®Google Scholar
• Burton DA, Nicholson G, Hall GM. Anaesthesia in elderly patients with neurodegenerative disorders: special considerations. Drugs Aging. 2004;21:229–242. doi:10.2165/00002512-200421040-0000215012169
   PubMed Web of Science ®Google Scholar
• Brennan KA, Genever RW. Managing Parkinson’s disease during surgery. BMJ. 2010;341:c5718. doi:10.1136/bmj.c571821041319
   PubMed Web of Science ®Google Scholar
• Abou-Raya S, Helmii M, Abou-Raya A. Bone and mineral metabolism in older adults with Parkinson’s disease. Age Ageing. 2009;38:675–680. doi:10.1093/ageing/afp13719684354
   PubMed Web of Science ®Google Scholar
• Yiannopoulou KG, Papageorgiou SG, Anastasiou IP, et al. Prevalence of parkinsonism in older patients with hip fracture. Hip Int. 2011;21:351–355. doi:10.5301/hip.2011.840221698587
   PubMed Web of Science ®Google Scholar
• Invernizzi M, Carda S, Viscontini GS, et al. Osteoporosis in Parkinson’s disease. Parkinsonism Relat Disord. 2009;15:339–346. doi:10.1016/j.parkreldis.2009.02.00919346153
   PubMed Web of Science ®Google Scholar
• Eventov I, Moreno M, Geller E, Tardiman R, Salama R. Hip fractures in patients with Parkinson’s syndrome. J Trauma. 1983;23:98–101. doi:10.1097/00005373-198302000-000046827645
   PubMedGoogle Scholar